These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22234915)

  • 1. Impact of a health safety warning and prior authorisation on the use of piroxicam: a time-series study.
    Carracedo-Martínez E; Pia-Morandeira A; Figueiras A
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):281-4. PubMed ID: 22234915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).
    Vlahovic-Palcevski V; Wettermark B; Bergman U
    Eur J Clin Pharmacol; 2002 Jun; 58(3):209-14. PubMed ID: 12107607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irish Medicines Board safety warnings: do they affect prescribing rates in primary care?
    Musleh S; Kraus S; Bennett K; Zaharan NL
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):979-86. PubMed ID: 21774032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
    Ravaud P; Auleley GR; Ayral X; Marre JP; Amor B
    J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease.
    Schüetz E; Sánchez J; García-Barbal J; Sarti JF; Reuter C; Harrison FJ
    Eur J Rheumatol Inflamm; 1991; 11(4):21-8. PubMed ID: 1365486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piroxicam: restriction of indications: labelling change. Only half-measures.
    Prescrire Int; 2008 Oct; 17(97):193. PubMed ID: 19534045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
    Dick WC; Bulstra S; Schardijn GH; Feenstra RM
    Clin Ther; 1992; 14(4):517-26. PubMed ID: 1388092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.
    Selçuk E; Gomel M; Apaydin S; Köse T; Tuglular I
    Int J Clin Pharmacol Res; 1998; 18(1):21-9. PubMed ID: 9604731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nonsteroidal anti-inflammatory agents of the group of oxicam derivatives].
    Suţeanu S; Manuchian M; Oancea P; Macarie O
    Med Interna; 1992; 44(1):16-23. PubMed ID: 1345346
    [No Abstract]   [Full Text] [Related]  

  • 10. Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazone.
    Stewart KA; Natzke BM; Williams T; Granger E; Casscells SW; Croghan TW
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1048-52. PubMed ID: 19655338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA; Pokryshkin VI
    Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain].
    Dolci G; Ripari M; Pacifici L; Umile A
    Minerva Stomatol; 1993 May; 42(5):235-41. PubMed ID: 8413108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.
    Fischer MA; Schneeweiss S; Avorn J; Solomon DH
    N Engl J Med; 2004 Nov; 351(21):2187-94. PubMed ID: 15548779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piroxicam gel, compared to EMLA cream is associated with less pain after venous cannulation in volunteers.
    Dutta A; Puri GD; Wig J
    Can J Anaesth; 2003 Oct; 50(8):775-8. PubMed ID: 14525815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR
    Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers.
    Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M
    Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis.
    Ansari F; Gray K; Nathwani D; Phillips G; Ogston S; Ramsay C; Davey P
    J Antimicrob Chemother; 2003 Nov; 52(5):842-8. PubMed ID: 14563900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do non-steroidal anti-inflammatory drugs influence chronic inflammation? The effects of piroxicam on chronic antigen-induced arthritis in rats.
    Sigurdardottir SL; Freysdottir J; Vikingsdottir T; Valdimarsson H; Vikingsson A
    Scand J Rheumatol; 2008; 37(6):469-76. PubMed ID: 19005999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term evaluation of the treatment of osteoarthritis.
    Zizic TM; Sutton JD; Stevens MB
    Am J Med; 1986 Nov; 81(5B):29-35. PubMed ID: 3538868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.